Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Nelson

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Trials|April 1, 2016
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trialSteven Y C Tong, Jane Nelson, David L Paterson, et al.
Pneumonia (Nathan Qld.)|January 4, 2019
Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of AustraliaMichael J Binks, Sarah A Moberley, Anne Balloch, et al.
Vaccine|November 4, 2015
PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, AustraliaMichael J Binks, Sarah A Moberley, Anne Balloch, et al.
BMJ Open Respiratory Research|August 16, 2023
Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the 'D-Kids' study protocolMichael J Binks, Amy S Bleakley, Susan J Pizzutto, et al.
Plos Pathogens|March 7, 2022
HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous peopleJennifer R Habel, Andrea T Nguyen, Louise C Rowntree, et al.
Trials|December 3, 2021
INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trialSandawana William Majoni, Jane Nelson, Darren Germaine, et al.
Immunology and Cell Biology|September 19, 2023
Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19Wuji Zhang, E Bridie Clemens, Lukasz Kedzierski, et al.
Research Involvement and Engagement|July 15, 2024
Engagement and partnership with consumers and communities in the co-design and conduct of Research: Lessons from the INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis (INFERR) clinical trialStephanie Long, Cheryl Ross, Joan Koops, et al.
Nature Communications|June 5, 2026
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidityMorgan J Skinner, Lukasz Kedzierski, Ruth A Purcell, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Trials|April 1, 2016
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trialSteven Y C Tong, Jane Nelson, David L Paterson, et al.
Pneumonia (Nathan Qld.)|January 4, 2019
Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of AustraliaMichael J Binks, Sarah A Moberley, Anne Balloch, et al.
Vaccine|November 4, 2015
PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, AustraliaMichael J Binks, Sarah A Moberley, Anne Balloch, et al.
BMJ Open Respiratory Research|August 16, 2023
Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the 'D-Kids' study protocolMichael J Binks, Amy S Bleakley, Susan J Pizzutto, et al.
Plos Pathogens|March 7, 2022
HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous peopleJennifer R Habel, Andrea T Nguyen, Louise C Rowntree, et al.
Trials|December 3, 2021
INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trialSandawana William Majoni, Jane Nelson, Darren Germaine, et al.
Immunology and Cell Biology|September 19, 2023
Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19Wuji Zhang, E Bridie Clemens, Lukasz Kedzierski, et al.
Research Involvement and Engagement|July 15, 2024
Engagement and partnership with consumers and communities in the co-design and conduct of Research: Lessons from the INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis (INFERR) clinical trialStephanie Long, Cheryl Ross, Joan Koops, et al.
Nature Communications|June 5, 2026
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidityMorgan J Skinner, Lukasz Kedzierski, Ruth A Purcell, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.
Pageof 7